Browse by author
Lookup NU author(s): Professor Andrew FisherORCiD, Dr Lee Borthwick
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Copyright © 2023 Th Authors, some rights reserved.Macrophages are central orchestrators of the tissue response to injury, with distinct macrophage activation states playing key roles in fibrosis progression and resolution. Identifying key macrophage populations found in human fibrotic tissues could lead to new treatments for fibrosis. Here, we used human liver and lung singlecell RNA sequencing datasets to identify a subset of CD9+TREM2+ macrophages that express SPP1, GPNMB, FABP5, and CD63. In both human and murine hepatic and pulmonary fibrosis, these macrophages were enriched at the outside edges of scarring and adjacent to activated mesenchymal cells. Neutrophils expressing MMP9, which participates in the activation of TGF-β1, and the type 3 cytokines GM-CSF and IL-17A coclustered with these macrophages. In vitro, GM-CSF, IL-17A, and TGF-β1 drive the differentiation of human monocytes into macrophages expressing scar-associated markers. Such differentiated cells could degrade collagen IV but not collagen I and promote TGF-β1–induced collagen I deposition by activated mesenchymal cells. In murine models blocking GM-CSF, IL-17A or TGF-β1 reduced scar-associated macrophage expansion and hepatic or pulmonary fibrosis. Our work identifies a highly specific macrophage population to which we assign a profibrotic role across species and tissues. It further provides a strategy for unbiased discovery, triage, and preclinical validation of therapeutic targets based on this fibrogenic macrophage population.
Author(s): Fabre T, Barron AMS, Christensen SM, Asano S, Bound K, Lech MP, Wadsworth MH, Chen X, Wang C, Wang J, McMahon J, Schlerman F, White A, Kravarik KM, Fisher AJ, Borthwick LA, Hart KM, Henderson NC, Wynn TA, Dower K
Publication type: Article
Publication status: Published
Journal: Science Immunology
Year: 2023
Volume: 8
Issue: 82
Print publication date: 01/04/2023
Online publication date: 07/04/2023
Acceptance date: 16/03/2023
ISSN (electronic): 2470-9468
Publisher: American Association for the Advancement of Science
URL: https://doi.org/10.1126/sciimmunol.add8945
DOI: 10.1126/sciimmunol.add8945
PubMed id: 37027478
Altmetrics provided by Altmetric